Cited by 92Liver Disease and TransplantationAdvanced MRI Techniques and ApplicationsNeural and Behavioral Psychology Studies

Enhancement of functional connectivity, working memory and inhibitory control on multi-modal brain MR imaging with rifaximin in cirrhosis: implications for the gut-liver-brain axis

Open access
Ahluwalia, Vishwadeep, Wade, James B., Heuman, Douglas M., Hammeke, Thomas A., Sanyal, Arun J., Sterling, Richard K., Stravitz, R. Todd, Luketic, Velimir +9 more·2014·Metabolic Brain Disease

Abstract

Unlabelled Minimal hepatic encephalopathy (MHE) impairs daily functioning in cirrhosis, but its functional brain impact is not completely understood. To evaluate the effect of rifaximin, a gut-specific antibiotic, on the gut-liver-brain axis in MHE.Hypothesis Rifaximin will reduce endotoxemia, enhance cognition, increase activation during working memory(N-back) and reduce activation needed for inhibitory control tasks.Methods Cirrhotics with MHE underwent baseline endotoxin and cognitive testing, then underwent fMRI, diffusion tensor imaging and MR spectroscopy(MRS). On fMRI, two tasks; N-back (outcome: correct responses) and inhibitory control tests(outcomes: lure inhibition) were performed. All procedures were repeated after 8 weeks of rifaximin. RESULTS were compared before/after rifaximin.Results 20 MHE patients (59.7 years) were included; sixteen completed pre/post-rifaximin scanning with 92% medication compliance. Pre-rifaximin patients had cognitive impairment. At trial-end, there was a significantly higher correct 2-back responses, ICT lure inhibitions and reduced endotoxemia(p = 0.002). This was accompanied by significantly higher activation from baseline in subcortical structures (thalamus, caudate, insula and hippocampus) and left parietal operculum (LPO) during N-back, decrease in fronto-parietal activation required for inhibiting lures, including LPO during ICT compared to baseline values. Connectivity studies in N-back showed significant shifts in linkages after therapy in fronto-parietal regions with a reduction in fractional anisotropy (FA) but not mean diffusivity (MD), and no change in MRS metabolites at the end of the trial. A significant improvement in cognition including working memory and inhibitory control, and fractional anisotropy without effect on MD or MRS, through modulation of fronto-parietal and subcortical activation and connectivity was seen after open-label rifaximin therapy in MHE.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11011-014-9507-6

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Administration of non-absorbable antibiotics in patients with hepatic encephalopathy and mild cognitive impairment improves cognitive performance, subcortical brain activity, fronto-parietal connectivity, and serum metabolomic profile.

    “Administration of non-absorbable antibiotics in patients with hepatic encephalopathy and mild cognitive impairment improves cognitive performance, subcortical brain activity, fronto-parietal connectivity, and serum metabolomic profile (418, 419).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ahluwalia, V., Wade, J. B., Heuman, D. M., Hammeke, T. A., Sanyal, A. J., Sterling, R. K., Stravitz, R. T., Luketic, V., Siddiqui, M. S., Puri, P., Fuchs, M., Lennon, M. J., Kraft, K. A., Gilles, H., White, M. B., Noble, N. A., & Bajaj, J. S.
Affiliations
  • Virginia Commonwealth University (US)
  • Medical College of Wisconsin (US)
Corresponding author
Bajaj, Jasmohan S.
Venue
Metabolic Brain Disease
Published
2014-03-04
Volume
29
Issue
4
Pages
1017-1025
ISSN
  • 0885-7490 (ISSN-L)
  • 1573-7365
OpenAlex
W2025612159
Cited by
92
References
40
Citations by year
2026: 3 · 2025: 8 · 2024: 11 · 2023: 6 · 2022: 9 · 2021: 9 · 2020: 2 · 2019: 7 · 2018: 14 · 2017: 5 · 2016: 7 · 2015: 6 · 2014: 4
FWCI
4.11
Type
journal article
Language
en
Open access
Locations
  • Metabolic Brain Disease (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institute on Alcohol Abuse and Alcoholism (R01AA020203)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK087913)
  • National Center for Complementary and Integrative Health (U01AT004428)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
Keywords
rifaximin, minimal hepatic encephalopathy, liver cirrhosis, gut-liver-brain axis, endotoxemia, working memory, inhibitory control, functional connectivity, n-back task, subcortical activation, fractional anisotropy, brain metabolites, cognitive impairment
MeSH terms
Rifaximin, Anti-Bacterial Agents, Brain, Brain Chemistry, Cognition Disorders, Female, Hepatic Encephalopathy, Humans, Inhibition, Psychological, Intestines, Liver, Liver Cirrhosis, Magnetic Resonance Imaging, Male, Memory, Short-Term, Middle Aged, Neuropsychological Tests, Magnetic Resonance Spectroscopy, Rifamycins, Bacterial Translocation, Diffusion Tensor Imaging, Functional Neuroimaging, Connectome, Microbiota, Multimodal Imaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review